http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016122289-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 |
filingDate | 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c556a9c7b151fa1a0bec72cb7b2efa6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a17bb7fc0a30cbd24173f639dae38167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69d6506b5961836c24ca50b6c1c39fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa2c4ce06d9d7caaf3a8dd805cb203c7 |
publicationDate | 2016-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2016122289-A2 |
titleOfInvention | Composition including verbenone derivative for preventing or alleviating side effects of reperfusion procedure |
abstract | The present invention relates to a pharmaceutical composition for preventing or alleviating side effects caused by a reperfusion procedure. More specifically, the present invention relates to a composition including a verbenone derivative having the structure of Chemical Formula 1 or a pharmaceutically acceptable salt thereof for preventing or alleviating side effects caused by a reperfusion procedure, and a method of preventing or alleviating side effects caused by the reperfusion procedure, by administering the verbenone derivative or a pharmaceutically acceptable salt thereof before, concurrently with or after the reperfusion procedure. Furthermore, the present invention relates to a composition including a verbenone derivative having the structure of Chemical Formula 1 or a pharmaceutically acceptable salt thereof for treating cerebrovascular diseases, arteriosclerosis or cardiovascular diseases in a patient who has been subjected to the reperfusion procedure and a method for treating cerebrovascular diseases, arteriosclerosis or cardiovascular diseases by administering the verbenone derivative or a pharmaceutically acceptable salt thereof before, concurrently with or after the reperfusion procedure. |
priorityDate | 2015-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 226.